

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 6.66114284 |
| 2 | viral transcription (GO:0019083) | 6.29119760 |
| 3 | DNA deamination (GO:0045006) | 6.24769787 |
| 4 | translational termination (GO:0006415) | 6.05643670 |
| 5 | ribosomal small subunit biogenesis (GO:0042274) | 5.84098688 |
| 6 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 5.54290915 |
| 7 | cotranslational protein targeting to membrane (GO:0006613) | 5.45097864 |
| 8 | protein targeting to ER (GO:0045047) | 5.40728286 |
| 9 | translational elongation (GO:0006414) | 5.40201671 |
| 10 | protein localization to endoplasmic reticulum (GO:0070972) | 5.16200064 |
| 11 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 5.10111179 |
| 12 | maturation of SSU-rRNA (GO:0030490) | 4.96740460 |
| 13 | viral life cycle (GO:0019058) | 4.81656985 |
| 14 | translational initiation (GO:0006413) | 4.71024251 |
| 15 | cellular protein complex disassembly (GO:0043624) | 4.70987216 |
| 16 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.63525966 |
| 17 | proteasome assembly (GO:0043248) | 4.62011671 |
| 18 | ribosomal large subunit biogenesis (GO:0042273) | 4.56513952 |
| 19 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.39366096 |
| 20 | cytochrome complex assembly (GO:0017004) | 4.37469726 |
| 21 | translation (GO:0006412) | 4.32011710 |
| 22 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.30585020 |
| 23 | protein neddylation (GO:0045116) | 4.24693058 |
| 24 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.14248074 |
| 25 | protein complex disassembly (GO:0043241) | 4.06093728 |
| 26 | ATP synthesis coupled proton transport (GO:0015986) | 4.05140790 |
| 27 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.05140790 |
| 28 | ATP biosynthetic process (GO:0006754) | 4.04287491 |
| 29 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.01889084 |
| 30 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.00973723 |
| 31 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.89359959 |
| 32 | macromolecular complex disassembly (GO:0032984) | 3.86043172 |
| 33 | regulation of mitochondrial translation (GO:0070129) | 3.85207014 |
| 34 | hydrogen ion transmembrane transport (GO:1902600) | 3.84352109 |
| 35 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.84031362 |
| 36 | DNA strand elongation (GO:0022616) | 3.83390020 |
| 37 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.83259867 |
| 38 | formation of translation preinitiation complex (GO:0001731) | 3.73725342 |
| 39 | spliceosomal snRNP assembly (GO:0000387) | 3.72969668 |
| 40 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.67876932 |
| 41 | inner mitochondrial membrane organization (GO:0007007) | 3.67573092 |
| 42 | termination of RNA polymerase III transcription (GO:0006386) | 3.65136528 |
| 43 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.65136528 |
| 44 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.64598984 |
| 45 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.64586726 |
| 46 | negative regulation of ligase activity (GO:0051352) | 3.63940173 |
| 47 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.63940173 |
| 48 | protein localization to mitochondrion (GO:0070585) | 3.62768943 |
| 49 | establishment of integrated proviral latency (GO:0075713) | 3.61572583 |
| 50 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.61385908 |
| 51 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.60471518 |
| 52 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.57821370 |
| 53 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.56505519 |
| 54 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.56505519 |
| 55 | pseudouridine synthesis (GO:0001522) | 3.56218373 |
| 56 | rRNA processing (GO:0006364) | 3.55805246 |
| 57 | cellular component biogenesis (GO:0044085) | 3.55234607 |
| 58 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.54905196 |
| 59 | telomere maintenance via recombination (GO:0000722) | 3.54145118 |
| 60 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.53988829 |
| 61 | NADH dehydrogenase complex assembly (GO:0010257) | 3.53988829 |
| 62 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.53988829 |
| 63 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.52652260 |
| 64 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.52652260 |
| 65 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.52652260 |
| 66 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.52127667 |
| 67 | protein targeting to membrane (GO:0006612) | 3.51904601 |
| 68 | rRNA modification (GO:0000154) | 3.51652317 |
| 69 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 3.51102737 |
| 70 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.50377379 |
| 71 | protein complex biogenesis (GO:0070271) | 3.47800959 |
| 72 | oxidative phosphorylation (GO:0006119) | 3.47301968 |
| 73 | cullin deneddylation (GO:0010388) | 3.46941332 |
| 74 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.44477628 |
| 75 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.44395332 |
| 76 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.42493579 |
| 77 | protein deneddylation (GO:0000338) | 3.42417208 |
| 78 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.42394300 |
| 79 | respiratory electron transport chain (GO:0022904) | 3.41402703 |
| 80 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.40535238 |
| 81 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.40535238 |
| 82 | protein targeting to mitochondrion (GO:0006626) | 3.39728394 |
| 83 | rRNA metabolic process (GO:0016072) | 3.39070887 |
| 84 | intracellular protein transmembrane import (GO:0044743) | 3.38633463 |
| 85 | respiratory chain complex IV assembly (GO:0008535) | 3.37048500 |
| 86 | mRNA catabolic process (GO:0006402) | 3.35559537 |
| 87 | chaperone-mediated protein transport (GO:0072321) | 3.35519898 |
| 88 | proton transport (GO:0015992) | 3.35498011 |
| 89 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.35377840 |
| 90 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.35235303 |
| 91 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.34767192 |
| 92 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.34767192 |
| 93 | mitochondrial transport (GO:0006839) | 3.32994999 |
| 94 | electron transport chain (GO:0022900) | 3.32943198 |
| 95 | establishment of protein localization to mitochondrion (GO:0072655) | 3.31366748 |
| 96 | DNA replication initiation (GO:0006270) | 3.31233715 |
| 97 | chromatin remodeling at centromere (GO:0031055) | 3.30810799 |
| 98 | hydrogen transport (GO:0006818) | 3.29077197 |
| 99 | spliceosomal complex assembly (GO:0000245) | 3.24767584 |
| 100 | peptidyl-histidine modification (GO:0018202) | 3.24645215 |
| 101 | transcription-coupled nucleotide-excision repair (GO:0006283) | 3.23046464 |
| 102 | 7-methylguanosine mRNA capping (GO:0006370) | 3.22592679 |
| 103 | aerobic respiration (GO:0009060) | 3.21066770 |
| 104 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.20963301 |
| 105 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.20141736 |
| 106 | nucleoside triphosphate biosynthetic process (GO:0009142) | 3.19858881 |
| 107 | 7-methylguanosine RNA capping (GO:0009452) | 3.19056483 |
| 108 | RNA capping (GO:0036260) | 3.19056483 |
| 109 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.17997401 |
| 110 | mitotic recombination (GO:0006312) | 3.17758212 |
| 111 | RNA catabolic process (GO:0006401) | 3.17683949 |
| 112 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.17456973 |
| 113 | purine ribonucleoside monophosphate biosynthetic process (GO:0009168) | 3.17435684 |
| 114 | purine nucleoside monophosphate biosynthetic process (GO:0009127) | 3.17435684 |
| 115 | CENP-A containing nucleosome assembly (GO:0034080) | 3.17367663 |
| 116 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.16570698 |
| 117 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.16570698 |
| 118 | GTP biosynthetic process (GO:0006183) | 3.14574903 |
| 119 | DNA replication checkpoint (GO:0000076) | 3.12421720 |
| 120 | positive regulation of ligase activity (GO:0051351) | 3.10066089 |
| 121 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.08479447 |
| 122 | establishment of viral latency (GO:0019043) | 3.08362662 |
| 123 | aldehyde catabolic process (GO:0046185) | 3.08138574 |
| 124 | telomere maintenance via telomere lengthening (GO:0010833) | 3.07207137 |
| 125 | viral mRNA export from host cell nucleus (GO:0046784) | 3.01997039 |
| 126 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.96639184 |
| 127 | protein-cofactor linkage (GO:0018065) | 2.93028407 |
| 128 | DNA damage response, detection of DNA damage (GO:0042769) | 2.92689145 |
| 129 | ubiquinone biosynthetic process (GO:0006744) | 2.86333358 |
| 130 | base-excision repair, AP site formation (GO:0006285) | 2.83444637 |
| 131 | UTP biosynthetic process (GO:0006228) | 2.79931050 |
| 132 | protein targeting (GO:0006605) | 2.79577232 |
| 133 | ribonucleoside monophosphate biosynthetic process (GO:0009156) | 2.77820931 |
| 134 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.77610884 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.74275921 |
| 2 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.33692687 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.26876474 |
| 4 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.19275385 |
| 5 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.01966013 |
| 6 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.90093119 |
| 7 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.78011269 |
| 8 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.65577425 |
| 9 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.43892516 |
| 10 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.19432238 |
| 11 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 3.18997073 |
| 12 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.17212521 |
| 13 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.05136820 |
| 14 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.87226541 |
| 15 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.81124915 |
| 16 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.75630522 |
| 17 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.71574396 |
| 18 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.62459496 |
| 19 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.56107136 |
| 20 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.55260060 |
| 21 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.53955341 |
| 22 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.33780823 |
| 23 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.30361982 |
| 24 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.25890587 |
| 25 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.24240712 |
| 26 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.23539278 |
| 27 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.21877618 |
| 28 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.21169698 |
| 29 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.17276755 |
| 30 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.08332020 |
| 31 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.07660285 |
| 32 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.06753765 |
| 33 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.04398149 |
| 34 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.02654744 |
| 35 | TTF2_22483619_ChIP-Seq_HELA_Human | 2.02467616 |
| 36 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.97276145 |
| 37 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.88126166 |
| 38 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.81161655 |
| 39 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.80951407 |
| 40 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.78884284 |
| 41 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.78695175 |
| 42 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.75032159 |
| 43 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.72607854 |
| 44 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.70708269 |
| 45 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.62059609 |
| 46 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.55414323 |
| 47 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.52501400 |
| 48 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.52442392 |
| 49 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.51306960 |
| 50 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.49486533 |
| 51 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48838068 |
| 52 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.46983452 |
| 53 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.46742052 |
| 54 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.46042463 |
| 55 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.45823394 |
| 56 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.44730615 |
| 57 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.40665475 |
| 58 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.38332087 |
| 59 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.36954166 |
| 60 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.34677287 |
| 61 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.31090649 |
| 62 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.26864856 |
| 63 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.26482586 |
| 64 | VDR_22108803_ChIP-Seq_LS180_Human | 1.25924903 |
| 65 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.25468971 |
| 66 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.24019301 |
| 67 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.22729125 |
| 68 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.21223657 |
| 69 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.20800355 |
| 70 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.17200287 |
| 71 | EWS_26573619_Chip-Seq_HEK293_Human | 1.15416926 |
| 72 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.15361362 |
| 73 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.15233740 |
| 74 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.13618932 |
| 75 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.11672702 |
| 76 | FUS_26573619_Chip-Seq_HEK293_Human | 1.11192602 |
| 77 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.09803997 |
| 78 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.08022449 |
| 79 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.07938395 |
| 80 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.06962485 |
| 81 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.06843332 |
| 82 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.06560766 |
| 83 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.05204639 |
| 84 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.04477809 |
| 85 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.03335295 |
| 86 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.01972649 |
| 87 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.01971152 |
| 88 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.00594827 |
| 89 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.00382794 |
| 90 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.99310723 |
| 91 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.99231719 |
| 92 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98899146 |
| 93 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.97226865 |
| 94 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.95703958 |
| 95 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.95010088 |
| 96 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94634818 |
| 97 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.93851628 |
| 98 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.92881828 |
| 99 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.92685371 |
| 100 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.92225863 |
| 101 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.90115238 |
| 102 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.89380614 |
| 103 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.88528593 |
| 104 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.87474397 |
| 105 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.87447114 |
| 106 | MYC_22102868_ChIP-Seq_BL_Human | 0.87444953 |
| 107 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87418391 |
| 108 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.86393189 |
| 109 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.86108527 |
| 110 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.85274380 |
| 111 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.85199596 |
| 112 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.83711194 |
| 113 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.82512459 |
| 114 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.80987174 |
| 115 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.80410287 |
| 116 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.80340289 |
| 117 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.80287626 |
| 118 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.79719278 |
| 119 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.79704686 |
| 120 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.77064145 |
| 121 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.76635094 |
| 122 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.76524581 |
| 123 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.73260784 |
| 124 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.71412986 |
| 125 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.70737553 |
| 126 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.68380648 |
| 127 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.66579033 |
| 128 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.65024969 |
| 129 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.65009440 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 4.44433889 |
| 2 | MP0009379_abnormal_foot_pigmentation | 3.78850429 |
| 3 | MP0004957_abnormal_blastocyst_morpholog | 3.53360343 |
| 4 | MP0003186_abnormal_redox_activity | 2.99830822 |
| 5 | MP0003077_abnormal_cell_cycle | 2.97971299 |
| 6 | MP0010094_abnormal_chromosome_stability | 2.83204164 |
| 7 | MP0002837_dystrophic_cardiac_calcinosis | 2.80126220 |
| 8 | MP0008058_abnormal_DNA_repair | 2.70335173 |
| 9 | MP0003111_abnormal_nucleus_morphology | 2.51923507 |
| 10 | MP0004145_abnormal_muscle_electrophysio | 2.48100415 |
| 11 | MP0006036_abnormal_mitochondrial_physio | 2.46691360 |
| 12 | MP0003806_abnormal_nucleotide_metabolis | 2.44933536 |
| 13 | MP0002396_abnormal_hematopoietic_system | 2.44260726 |
| 14 | MP0001835_abnormal_antigen_presentation | 2.43951618 |
| 15 | MP0009333_abnormal_splenocyte_physiolog | 2.43662378 |
| 16 | MP0008007_abnormal_cellular_replicative | 2.41873950 |
| 17 | MP0008932_abnormal_embryonic_tissue | 2.18161243 |
| 18 | MP0002132_abnormal_respiratory_system | 2.15838532 |
| 19 | MP0003787_abnormal_imprinting | 2.12063252 |
| 20 | MP0008057_abnormal_DNA_replication | 2.03527469 |
| 21 | MP0006072_abnormal_retinal_apoptosis | 1.99854635 |
| 22 | MP0003136_yellow_coat_color | 1.98300167 |
| 23 | MP0000490_abnormal_crypts_of | 1.96293071 |
| 24 | MP0002148_abnormal_hypersensitivity_rea | 1.90466247 |
| 25 | MP0006292_abnormal_olfactory_placode | 1.90347001 |
| 26 | MP0003786_premature_aging | 1.83879571 |
| 27 | MP0009785_altered_susceptibility_to | 1.83822254 |
| 28 | MP0005671_abnormal_response_to | 1.76927318 |
| 29 | MP0006035_abnormal_mitochondrial_morpho | 1.75827049 |
| 30 | MP0003718_maternal_effect | 1.74940526 |
| 31 | MP0003646_muscle_fatigue | 1.71138810 |
| 32 | MP0001853_heart_inflammation | 1.70879734 |
| 33 | MP0001529_abnormal_vocalization | 1.69876963 |
| 34 | MP0003763_abnormal_thymus_physiology | 1.65541575 |
| 35 | MP0002736_abnormal_nociception_after | 1.63872128 |
| 36 | MP0002638_abnormal_pupillary_reflex | 1.61809527 |
| 37 | MP0001293_anophthalmia | 1.60871176 |
| 38 | MP0003121_genomic_imprinting | 1.58637738 |
| 39 | MP0005075_abnormal_melanosome_morpholog | 1.58062465 |
| 40 | MP0003724_increased_susceptibility_to | 1.56912573 |
| 41 | MP0002398_abnormal_bone_marrow | 1.52029544 |
| 42 | MP0001984_abnormal_olfaction | 1.51653204 |
| 43 | MP0000685_abnormal_immune_system | 1.49697595 |
| 44 | MP0002653_abnormal_ependyma_morphology | 1.48304695 |
| 45 | MP0006276_abnormal_autonomic_nervous | 1.47982163 |
| 46 | MP0003656_abnormal_erythrocyte_physiolo | 1.45254154 |
| 47 | MP0005025_abnormal_response_to | 1.44211081 |
| 48 | MP0001986_abnormal_taste_sensitivity | 1.43493443 |
| 49 | MP0003436_decreased_susceptibility_to | 1.42509494 |
| 50 | MP0004147_increased_porphyrin_level | 1.42434678 |
| 51 | MP0005394_taste/olfaction_phenotype | 1.41911269 |
| 52 | MP0005499_abnormal_olfactory_system | 1.41911269 |
| 53 | MP0001968_abnormal_touch/_nociception | 1.40783788 |
| 54 | MP0000689_abnormal_spleen_morphology | 1.40428510 |
| 55 | MP0001800_abnormal_humoral_immune | 1.39944495 |
| 56 | MP0005000_abnormal_immune_tolerance | 1.37681355 |
| 57 | MP0010030_abnormal_orbit_morphology | 1.37050862 |
| 58 | MP0000313_abnormal_cell_death | 1.37023076 |
| 59 | MP0002722_abnormal_immune_system | 1.36853468 |
| 60 | MP0003123_paternal_imprinting | 1.34613530 |
| 61 | MP0002420_abnormal_adaptive_immunity | 1.34144197 |
| 62 | MP0005551_abnormal_eye_electrophysiolog | 1.34129593 |
| 63 | MP0002429_abnormal_blood_cell | 1.32455829 |
| 64 | MP0002723_abnormal_immune_serum | 1.32171569 |
| 65 | MP0001819_abnormal_immune_cell | 1.32131010 |
| 66 | MP0006054_spinal_hemorrhage | 1.31335664 |
| 67 | MP0002234_abnormal_pharynx_morphology | 1.31051679 |
| 68 | MP0005084_abnormal_gallbladder_morpholo | 1.31023756 |
| 69 | MP0003941_abnormal_skin_development | 1.30784631 |
| 70 | MP0002452_abnormal_antigen_presenting | 1.29842584 |
| 71 | MP0009046_muscle_twitch | 1.28976641 |
| 72 | MP0000716_abnormal_immune_system | 1.28366417 |
| 73 | MP0001545_abnormal_hematopoietic_system | 1.26250622 |
| 74 | MP0005397_hematopoietic_system_phenotyp | 1.26250622 |
| 75 | MP0003122_maternal_imprinting | 1.25925682 |
| 76 | MP0002019_abnormal_tumor_incidence | 1.25513746 |
| 77 | MP0004215_abnormal_myocardial_fiber | 1.25256907 |
| 78 | MP0003880_abnormal_central_pattern | 1.21844620 |
| 79 | MP0005645_abnormal_hypothalamus_physiol | 1.21768751 |
| 80 | MP0004142_abnormal_muscle_tone | 1.20896387 |
| 81 | MP0005253_abnormal_eye_physiology | 1.19624262 |
| 82 | MP0001764_abnormal_homeostasis | 1.18838739 |
| 83 | MP0000350_abnormal_cell_proliferation | 1.18741022 |
| 84 | MP0002272_abnormal_nervous_system | 1.17063422 |
| 85 | MP0000358_abnormal_cell_content/ | 1.16883535 |
| 86 | MP0000631_abnormal_neuroendocrine_gland | 1.14204160 |
| 87 | MP0002405_respiratory_system_inflammati | 1.13386329 |
| 88 | MP0003137_abnormal_impulse_conducting | 1.12390824 |
| 89 | MP0001730_embryonic_growth_arrest | 1.12013119 |
| 90 | MP0005646_abnormal_pituitary_gland | 1.10488214 |
| 91 | MP0004133_heterotaxia | 1.08662486 |
| 92 | MP0005174_abnormal_tail_pigmentation | 1.08488481 |
| 93 | MP0008995_early_reproductive_senescence | 1.08062308 |
| 94 | MP0005379_endocrine/exocrine_gland_phen | 1.07178616 |
| 95 | MP0000703_abnormal_thymus_morphology | 1.05828804 |
| 96 | MP0002822_catalepsy | 1.05620231 |
| 97 | MP0004808_abnormal_hematopoietic_stem | 1.05177286 |
| 98 | MP0001188_hyperpigmentation | 1.04934010 |
| 99 | MP0002419_abnormal_innate_immunity | 1.04518948 |
| 100 | MP0001905_abnormal_dopamine_level | 1.02848311 |
| 101 | MP0000343_altered_response_to | 1.02230698 |
| 102 | MP0005332_abnormal_amino_acid | 1.01551041 |
| 103 | MP0000372_irregular_coat_pigmentation | 0.99090178 |
| 104 | MP0002734_abnormal_mechanical_nocicepti | 0.99087796 |
| 105 | MP0008469_abnormal_protein_level | 0.97200813 |
| 106 | MP0003283_abnormal_digestive_organ | 0.96545296 |
| 107 | MP0002160_abnormal_reproductive_system | 0.94720439 |
| 108 | MP0001485_abnormal_pinna_reflex | 0.94297457 |
| 109 | MP0002095_abnormal_skin_pigmentation | 0.93185956 |
| 110 | MP0009745_abnormal_behavioral_response | 0.91398804 |
| 111 | MP0001790_abnormal_immune_system | 0.90325539 |
| 112 | MP0005387_immune_system_phenotype | 0.90325539 |
| 113 | MP0002102_abnormal_ear_morphology | 0.89569345 |
| 114 | MP0002210_abnormal_sex_determination | 0.87596033 |
| 115 | MP0000858_altered_metastatic_potential | 0.86382896 |
| 116 | MP0005266_abnormal_metabolism | 0.85815186 |
| 117 | MP0002277_abnormal_respiratory_mucosa | 0.85034938 |
| 118 | MP0003567_abnormal_fetal_cardiomyocyte | 0.84410566 |
| 119 | MP0008877_abnormal_DNA_methylation | 0.84027300 |
| 120 | MP0002233_abnormal_nose_morphology | 0.83113564 |
| 121 | MP0001845_abnormal_inflammatory_respons | 0.82715551 |
| 122 | MP0002090_abnormal_vision | 0.82077929 |
| 123 | MP0002163_abnormal_gland_morphology | 0.82044414 |
| 124 | MP0005408_hypopigmentation | 0.81804373 |
| 125 | MP0001697_abnormal_embryo_size | 0.81763555 |
| 126 | MP0001727_abnormal_embryo_implantation | 0.81620677 |
| 127 | MP0002735_abnormal_chemical_nociception | 0.81248723 |
| 128 | MP0002080_prenatal_lethality | 0.81175061 |
| 129 | MP0003315_abnormal_perineum_morphology | 0.80521069 |
| 130 | MP0009697_abnormal_copulation | 0.79400098 |
| 131 | MP0003011_delayed_dark_adaptation | 0.79113239 |
| 132 | MP0008872_abnormal_physiological_respon | 0.77617733 |
| 133 | MP0003937_abnormal_limbs/digits/tail_de | 0.77090742 |
| 134 | MP0000749_muscle_degeneration | 0.75988602 |
| 135 | MP0005389_reproductive_system_phenotype | 0.75684798 |
| 136 | MP0005636_abnormal_mineral_homeostasis | 0.75551804 |
| 137 | MP0001145_abnormal_male_reproductive | 0.74929788 |
| 138 | MP0002876_abnormal_thyroid_physiology | 0.74921242 |
| 139 | MP0001486_abnormal_startle_reflex | 0.74892197 |
| 140 | MP0003221_abnormal_cardiomyocyte_apopto | 0.74196689 |
| 141 | MP0005670_abnormal_white_adipose | 0.74060038 |
| 142 | MP0005195_abnormal_posterior_eye | 0.73778066 |
| 143 | MP0001929_abnormal_gametogenesis | 0.73774595 |
| 144 | MP0000653_abnormal_sex_gland | 0.73186917 |
| 145 | MP0000465_gastrointestinal_hemorrhage | 0.71997475 |
| 146 | MP0000015_abnormal_ear_pigmentation | 0.71669228 |
| 147 | MP0000049_abnormal_middle_ear | 0.71327446 |
| 148 | MP0001970_abnormal_pain_threshold | 0.70951061 |
| 149 | MP0010155_abnormal_intestine_physiology | 0.70330632 |
| 150 | MP0002938_white_spotting | 0.69991826 |
| 151 | MP0002733_abnormal_thermal_nociception | 0.69974243 |
| 152 | MP0002752_abnormal_somatic_nervous | 0.68782262 |
| 153 | MP0008775_abnormal_heart_ventricle | 0.68582855 |
| 154 | MP0005376_homeostasis/metabolism_phenot | 0.68468690 |
| 155 | MP0000026_abnormal_inner_ear | 0.67534064 |
| 156 | MP0008875_abnormal_xenobiotic_pharmacok | 0.67327514 |
| 157 | MP0005464_abnormal_platelet_physiology | 0.66436953 |
| 158 | MP0008789_abnormal_olfactory_epithelium | 0.65723009 |
| 159 | MP0001663_abnormal_digestive_system | 0.63543042 |
| 160 | MP0010368_abnormal_lymphatic_system | 0.61785065 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of cells of the erythroid lineage (HP:0012130) | 5.61760841 |
| 2 | Abnormal number of erythroid precursors (HP:0012131) | 5.45417280 |
| 3 | Mitochondrial inheritance (HP:0001427) | 4.97192140 |
| 4 | Hepatocellular necrosis (HP:0001404) | 4.97083857 |
| 5 | Acute necrotizing encephalopathy (HP:0006965) | 4.96580358 |
| 6 | Reticulocytopenia (HP:0001896) | 4.85254764 |
| 7 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 4.74281099 |
| 8 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 4.74281099 |
| 9 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.67080132 |
| 10 | Increased hepatocellular lipid droplets (HP:0006565) | 4.58155448 |
| 11 | Increased CSF lactate (HP:0002490) | 4.56264295 |
| 12 | Hepatic necrosis (HP:0002605) | 4.54257617 |
| 13 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 4.27244875 |
| 14 | Lipid accumulation in hepatocytes (HP:0006561) | 4.21839184 |
| 15 | Acute encephalopathy (HP:0006846) | 4.15586563 |
| 16 | Macrocytic anemia (HP:0001972) | 3.92378130 |
| 17 | 3-Methylglutaconic aciduria (HP:0003535) | 3.89965586 |
| 18 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.83926297 |
| 19 | Progressive macrocephaly (HP:0004481) | 3.83022462 |
| 20 | Increased serum lactate (HP:0002151) | 3.79479744 |
| 21 | Aplastic anemia (HP:0001915) | 3.66013324 |
| 22 | Increased intramyocellular lipid droplets (HP:0012240) | 3.63480459 |
| 23 | Increased serum pyruvate (HP:0003542) | 3.62345732 |
| 24 | Abnormality of glycolysis (HP:0004366) | 3.62345732 |
| 25 | Exertional dyspnea (HP:0002875) | 3.62004555 |
| 26 | Renal Fanconi syndrome (HP:0001994) | 3.60862015 |
| 27 | Pallor (HP:0000980) | 3.52314040 |
| 28 | Birth length less than 3rd percentile (HP:0003561) | 3.34230153 |
| 29 | Lactic acidosis (HP:0003128) | 3.31684672 |
| 30 | Increased muscle lipid content (HP:0009058) | 3.21907085 |
| 31 | Type I transferrin isoform profile (HP:0003642) | 3.17765559 |
| 32 | Respiratory failure (HP:0002878) | 3.16625376 |
| 33 | Respiratory difficulties (HP:0002880) | 3.16374618 |
| 34 | Exercise intolerance (HP:0003546) | 3.15049442 |
| 35 | Microvesicular hepatic steatosis (HP:0001414) | 3.03520283 |
| 36 | Abnormality of the anterior horn cell (HP:0006802) | 2.94064436 |
| 37 | Degeneration of anterior horn cells (HP:0002398) | 2.94064436 |
| 38 | Cerebral edema (HP:0002181) | 2.93933443 |
| 39 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.81132684 |
| 40 | Oral leukoplakia (HP:0002745) | 2.78607496 |
| 41 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.75564378 |
| 42 | Pancreatic fibrosis (HP:0100732) | 2.65899289 |
| 43 | Reduced antithrombin III activity (HP:0001976) | 2.64049718 |
| 44 | Hyperglycinemia (HP:0002154) | 2.56702357 |
| 45 | Petechiae (HP:0000967) | 2.51408450 |
| 46 | Cerebral hypomyelination (HP:0006808) | 2.47504931 |
| 47 | Poor head control (HP:0002421) | 2.45699055 |
| 48 | Breast hypoplasia (HP:0003187) | 2.44785516 |
| 49 | Pancreatic cysts (HP:0001737) | 2.41823786 |
| 50 | Thrombocytosis (HP:0001894) | 2.37693733 |
| 51 | Rough bone trabeculation (HP:0100670) | 2.36854589 |
| 52 | CNS demyelination (HP:0007305) | 2.33764661 |
| 53 | Optic disc pallor (HP:0000543) | 2.28688425 |
| 54 | Carpal bone hypoplasia (HP:0001498) | 2.28260572 |
| 55 | Leukodystrophy (HP:0002415) | 2.28217448 |
| 56 | Pancytopenia (HP:0001876) | 2.28018947 |
| 57 | Microretrognathia (HP:0000308) | 2.27006355 |
| 58 | Congenital, generalized hypertrichosis (HP:0004540) | 2.26693722 |
| 59 | True hermaphroditism (HP:0010459) | 2.26542972 |
| 60 | Myokymia (HP:0002411) | 2.24249544 |
| 61 | Muscle fiber atrophy (HP:0100295) | 2.23362771 |
| 62 | Methylmalonic acidemia (HP:0002912) | 2.21482206 |
| 63 | Type 2 muscle fiber atrophy (HP:0003554) | 2.18888472 |
| 64 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.17636109 |
| 65 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.17636109 |
| 66 | Abnormal protein glycosylation (HP:0012346) | 2.17636109 |
| 67 | Abnormal glycosylation (HP:0012345) | 2.17636109 |
| 68 | Medial flaring of the eyebrow (HP:0010747) | 2.16184726 |
| 69 | Emotional lability (HP:0000712) | 2.16178600 |
| 70 | Abnormality of alanine metabolism (HP:0010916) | 2.15926967 |
| 71 | Hyperalaninemia (HP:0003348) | 2.15926967 |
| 72 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.15926967 |
| 73 | IgM deficiency (HP:0002850) | 2.15580782 |
| 74 | Abnormality of midbrain morphology (HP:0002418) | 2.11992370 |
| 75 | Molar tooth sign on MRI (HP:0002419) | 2.11992370 |
| 76 | Multiple enchondromatosis (HP:0005701) | 2.10957652 |
| 77 | Hyperglycinuria (HP:0003108) | 2.07707910 |
| 78 | 11 pairs of ribs (HP:0000878) | 2.07633290 |
| 79 | Sclerocornea (HP:0000647) | 2.02845358 |
| 80 | Abnormality of the labia minora (HP:0012880) | 2.02688188 |
| 81 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.02145956 |
| 82 | Septo-optic dysplasia (HP:0100842) | 2.01677670 |
| 83 | Hypoglycemic coma (HP:0001325) | 2.01179190 |
| 84 | Abnormality of renal resorption (HP:0011038) | 1.99132910 |
| 85 | Trismus (HP:0000211) | 1.96896537 |
| 86 | X-linked dominant inheritance (HP:0001423) | 1.94443705 |
| 87 | Nephronophthisis (HP:0000090) | 1.93570588 |
| 88 | Lethargy (HP:0001254) | 1.91736131 |
| 89 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.91343751 |
| 90 | Gliosis (HP:0002171) | 1.90867090 |
| 91 | Recurrent abscess formation (HP:0002722) | 1.86412679 |
| 92 | Abnormality of reticulocytes (HP:0004312) | 1.85069885 |
| 93 | Colon cancer (HP:0003003) | 1.84436159 |
| 94 | Abnormality of serum amino acid levels (HP:0003112) | 1.83837781 |
| 95 | Secondary amenorrhea (HP:0000869) | 1.82373956 |
| 96 | Premature graying of hair (HP:0002216) | 1.82254606 |
| 97 | Ragged-red muscle fibers (HP:0003200) | 1.82097954 |
| 98 | Abnormality of glycine metabolism (HP:0010895) | 1.81151982 |
| 99 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.81151982 |
| 100 | Dicarboxylic aciduria (HP:0003215) | 1.80426350 |
| 101 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.80426350 |
| 102 | Hyperphosphaturia (HP:0003109) | 1.79021342 |
| 103 | Esophageal neoplasm (HP:0100751) | 1.78783207 |
| 104 | Neoplasm of head and neck (HP:0012288) | 1.78783207 |
| 105 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.77541032 |
| 106 | Nemaline bodies (HP:0003798) | 1.75809691 |
| 107 | Gait imbalance (HP:0002141) | 1.74434356 |
| 108 | Congenital primary aphakia (HP:0007707) | 1.73244198 |
| 109 | Glycosuria (HP:0003076) | 1.72576422 |
| 110 | Abnormality of urine glucose concentration (HP:0011016) | 1.72576422 |
| 111 | Cleft eyelid (HP:0000625) | 1.69377792 |
| 112 | Abnormal trabecular bone morphology (HP:0100671) | 1.69324570 |
| 113 | Maternal diabetes (HP:0009800) | 1.69264894 |
| 114 | Muscle fiber inclusion bodies (HP:0100299) | 1.68417774 |
| 115 | Blindness (HP:0000618) | 1.67933610 |
| 116 | Absent thumb (HP:0009777) | 1.67207068 |
| 117 | Nausea (HP:0002018) | 1.66050919 |
| 118 | Poor suck (HP:0002033) | 1.65647259 |
| 119 | Generalized aminoaciduria (HP:0002909) | 1.64335123 |
| 120 | Agnosia (HP:0010524) | 1.64176202 |
| 121 | Bone marrow hypocellularity (HP:0005528) | 1.63838167 |
| 122 | Sparse eyelashes (HP:0000653) | 1.63109704 |
| 123 | Vomiting (HP:0002013) | 1.62900149 |
| 124 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.61824649 |
| 125 | Nephrogenic diabetes insipidus (HP:0009806) | 1.61027672 |
| 126 | Recurrent bacterial skin infections (HP:0005406) | 1.60002643 |
| 127 | Progressive muscle weakness (HP:0003323) | 1.59430660 |
| 128 | Increased serum ferritin (HP:0003281) | 1.59367196 |
| 129 | Neutropenia (HP:0001875) | 1.57716447 |
| 130 | Anencephaly (HP:0002323) | 1.57542011 |
| 131 | Hypoglycemic seizures (HP:0002173) | 1.55998800 |
| 132 | Rib fusion (HP:0000902) | 1.55814096 |
| 133 | Methylmalonic aciduria (HP:0012120) | 1.55119538 |
| 134 | Cellular immunodeficiency (HP:0005374) | 1.54172634 |
| 135 | Tongue fasciculations (HP:0001308) | 1.53888498 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 5.61015214 |
| 2 | NME2 | 4.72945818 |
| 3 | BUB1 | 4.66657448 |
| 4 | STK16 | 3.74335114 |
| 5 | TLK1 | 3.30096906 |
| 6 | EIF2AK1 | 3.16286001 |
| 7 | WEE1 | 3.04420694 |
| 8 | PIM2 | 2.63272233 |
| 9 | VRK1 | 2.48214523 |
| 10 | EIF2AK3 | 2.18974732 |
| 11 | TESK2 | 2.14740423 |
| 12 | NUAK1 | 2.11020747 |
| 13 | BMPR1B | 2.01812067 |
| 14 | SRPK1 | 2.00221751 |
| 15 | WNK3 | 1.97613271 |
| 16 | OBSCN | 1.86172290 |
| 17 | BCKDK | 1.79422176 |
| 18 | DYRK3 | 1.77066792 |
| 19 | TAF1 | 1.76701783 |
| 20 | NME1 | 1.75890235 |
| 21 | CDC7 | 1.67981800 |
| 22 | KDR | 1.64004806 |
| 23 | ARAF | 1.55299379 |
| 24 | CDK19 | 1.49092398 |
| 25 | PHKG1 | 1.47801769 |
| 26 | PHKG2 | 1.47801769 |
| 27 | MAP4K2 | 1.45423942 |
| 28 | CSNK1G3 | 1.43406316 |
| 29 | IRAK4 | 1.40008697 |
| 30 | PLK4 | 1.38378845 |
| 31 | CSNK1G2 | 1.36851638 |
| 32 | PASK | 1.34277102 |
| 33 | CSNK1G1 | 1.32678083 |
| 34 | BRSK2 | 1.32229987 |
| 35 | CDK8 | 1.24767392 |
| 36 | MAP4K1 | 1.24749075 |
| 37 | MKNK1 | 1.24673829 |
| 38 | BLK | 1.21484007 |
| 39 | CDK7 | 1.20872532 |
| 40 | MAP3K11 | 1.19586017 |
| 41 | INSRR | 1.19068539 |
| 42 | PBK | 1.18299657 |
| 43 | TTK | 1.16975961 |
| 44 | TSSK6 | 1.16051984 |
| 45 | GRK1 | 1.13865595 |
| 46 | MAP3K12 | 1.12234411 |
| 47 | RPS6KA4 | 1.11799015 |
| 48 | SCYL2 | 1.11419279 |
| 49 | TEC | 1.10905875 |
| 50 | PAK4 | 1.06033406 |
| 51 | MST4 | 1.06008264 |
| 52 | PINK1 | 1.05551433 |
| 53 | KIT | 1.05182162 |
| 54 | CCNB1 | 1.04690101 |
| 55 | MAP2K7 | 1.03921903 |
| 56 | BTK | 1.02864906 |
| 57 | BRAF | 1.02401005 |
| 58 | PLK1 | 1.02346566 |
| 59 | PDK2 | 1.02122328 |
| 60 | ADRBK2 | 0.99932109 |
| 61 | ABL2 | 0.98384510 |
| 62 | TESK1 | 0.96741365 |
| 63 | AURKA | 0.93503926 |
| 64 | AURKB | 0.92553450 |
| 65 | LIMK1 | 0.92496316 |
| 66 | TBK1 | 0.92328887 |
| 67 | ILK | 0.91672272 |
| 68 | CSNK1A1L | 0.84955220 |
| 69 | TIE1 | 0.83804023 |
| 70 | IRAK3 | 0.83725770 |
| 71 | ZAP70 | 0.82552713 |
| 72 | MAP3K4 | 0.82407103 |
| 73 | PIM1 | 0.80256804 |
| 74 | FLT3 | 0.80220377 |
| 75 | CSNK2A1 | 0.79544827 |
| 76 | SYK | 0.79189751 |
| 77 | ATR | 0.78894221 |
| 78 | GRK7 | 0.77416552 |
| 79 | BRSK1 | 0.76079776 |
| 80 | ACVR1B | 0.75430156 |
| 81 | OXSR1 | 0.74090937 |
| 82 | MYLK | 0.73946769 |
| 83 | MKNK2 | 0.72759629 |
| 84 | TXK | 0.72669571 |
| 85 | RPS6KB2 | 0.71926492 |
| 86 | CAMKK2 | 0.70813455 |
| 87 | PRKCG | 0.69818374 |
| 88 | TYK2 | 0.68937886 |
| 89 | CSNK2A2 | 0.68855046 |
| 90 | DYRK2 | 0.68729314 |
| 91 | ZAK | 0.66994452 |
| 92 | GRK6 | 0.66829969 |
| 93 | LRRK2 | 0.66202086 |
| 94 | PAK1 | 0.66159953 |
| 95 | NEK1 | 0.64516879 |
| 96 | EIF2AK2 | 0.64385370 |
| 97 | LYN | 0.63678701 |
| 98 | IKBKB | 0.63401768 |
| 99 | RPS6KA5 | 0.63006582 |
| 100 | TNIK | 0.61375831 |
| 101 | MAP2K3 | 0.60809049 |
| 102 | RAF1 | 0.58588206 |
| 103 | MAPK13 | 0.57508050 |
| 104 | MOS | 0.57067102 |
| 105 | MUSK | 0.56964654 |
| 106 | CSF1R | 0.56174884 |
| 107 | FRK | 0.55373751 |
| 108 | TGFBR1 | 0.55339594 |
| 109 | IKBKE | 0.53618102 |
| 110 | GRK5 | 0.52835498 |
| 111 | CSNK1E | 0.50512982 |
| 112 | CLK1 | 0.49909851 |
| 113 | PLK2 | 0.49869989 |
| 114 | DAPK3 | 0.49112273 |
| 115 | MAP3K8 | 0.48277511 |
| 116 | STK24 | 0.48244710 |
| 117 | CHEK2 | 0.46964925 |
| 118 | TAOK2 | 0.46754136 |
| 119 | SIK3 | 0.46310765 |
| 120 | CSNK1A1 | 0.46255820 |
| 121 | MAPKAPK5 | 0.44322556 |
| 122 | PRKCI | 0.44226110 |
| 123 | NLK | 0.43996639 |
| 124 | STK4 | 0.43866543 |
| 125 | DAPK1 | 0.43825680 |
| 126 | NEK2 | 0.43714838 |
| 127 | PRKACA | 0.43380295 |
| 128 | PLK3 | 0.43328614 |
| 129 | RPS6KA6 | 0.42439271 |
| 130 | CAMK2A | 0.41834028 |
| 131 | CDK4 | 0.40836009 |
| 132 | CASK | 0.39087054 |
| 133 | ADRBK1 | 0.38517617 |
| 134 | CAMK2D | 0.37065881 |
| 135 | PRKCE | 0.36539616 |
| 136 | WNK4 | 0.35892015 |
| 137 | ATM | 0.35520678 |
| 138 | PIK3CG | 0.33731994 |
| 139 | CAMK2G | 0.32094456 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 5.56728954 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 4.43400170 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 3.95609868 |
| 4 | RNA polymerase_Homo sapiens_hsa03020 | 3.46762766 |
| 5 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.23252222 |
| 6 | Parkinsons disease_Homo sapiens_hsa05012 | 3.02209197 |
| 7 | Mismatch repair_Homo sapiens_hsa03430 | 2.99705108 |
| 8 | Spliceosome_Homo sapiens_hsa03040 | 2.73514067 |
| 9 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.62757099 |
| 10 | Protein export_Homo sapiens_hsa03060 | 2.59500495 |
| 11 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.49146619 |
| 12 | Base excision repair_Homo sapiens_hsa03410 | 2.44846422 |
| 13 | Homologous recombination_Homo sapiens_hsa03440 | 2.43361933 |
| 14 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.31457186 |
| 15 | Huntingtons disease_Homo sapiens_hsa05016 | 2.24114887 |
| 16 | Alzheimers disease_Homo sapiens_hsa05010 | 1.92248521 |
| 17 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.87336631 |
| 18 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.86392477 |
| 19 | RNA transport_Homo sapiens_hsa03013 | 1.83065697 |
| 20 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.50834550 |
| 21 | RNA degradation_Homo sapiens_hsa03018 | 1.47907245 |
| 22 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.45665308 |
| 23 | Basal transcription factors_Homo sapiens_hsa03022 | 1.45533298 |
| 24 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.42986237 |
| 25 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.42504605 |
| 26 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.37307816 |
| 27 | Purine metabolism_Homo sapiens_hsa00230 | 1.35818316 |
| 28 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.32155464 |
| 29 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.31989129 |
| 30 | Sulfur relay system_Homo sapiens_hsa04122 | 1.26848124 |
| 31 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.26455583 |
| 32 | Cell cycle_Homo sapiens_hsa04110 | 1.20265363 |
| 33 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.10734083 |
| 34 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.01772732 |
| 35 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.99111417 |
| 36 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.98946484 |
| 37 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.97295664 |
| 38 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.96563564 |
| 39 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.84150139 |
| 40 | Phototransduction_Homo sapiens_hsa04744 | 0.83998385 |
| 41 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.83105891 |
| 42 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.82780130 |
| 43 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.80884952 |
| 44 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.75185094 |
| 45 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.71959574 |
| 46 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.70559371 |
| 47 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.70018507 |
| 48 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.69981538 |
| 49 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.68411771 |
| 50 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.67244662 |
| 51 | Carbon metabolism_Homo sapiens_hsa01200 | 0.67069652 |
| 52 | Metabolic pathways_Homo sapiens_hsa01100 | 0.66730169 |
| 53 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.66431719 |
| 54 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.66173391 |
| 55 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.65905609 |
| 56 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.64799325 |
| 57 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.63827009 |
| 58 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.63673869 |
| 59 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.63027974 |
| 60 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.61957745 |
| 61 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.61436387 |
| 62 | Legionellosis_Homo sapiens_hsa05134 | 0.60233670 |
| 63 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.59527679 |
| 64 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.58143335 |
| 65 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.56541386 |
| 66 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.54830335 |
| 67 | Nicotine addiction_Homo sapiens_hsa05033 | 0.50917957 |
| 68 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.50699402 |
| 69 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.48824239 |
| 70 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.47120226 |
| 71 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.45869488 |
| 72 | Allograft rejection_Homo sapiens_hsa05330 | 0.43157002 |
| 73 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.43144835 |
| 74 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.41969520 |
| 75 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.41238941 |
| 76 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.40672086 |
| 77 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.39357085 |
| 78 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.38245931 |
| 79 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.37688416 |
| 80 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.36063848 |
| 81 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.35939587 |
| 82 | Peroxisome_Homo sapiens_hsa04146 | 0.35916690 |
| 83 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.35727006 |
| 84 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.34958952 |
| 85 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.34621800 |
| 86 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.34605646 |
| 87 | Shigellosis_Homo sapiens_hsa05131 | 0.34514134 |
| 88 | Asthma_Homo sapiens_hsa05310 | 0.34337930 |
| 89 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.34228361 |
| 90 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.33755899 |
| 91 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.33578691 |
| 92 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.32574240 |
| 93 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.32203568 |
| 94 | Leishmaniasis_Homo sapiens_hsa05140 | 0.31589544 |
| 95 | Measles_Homo sapiens_hsa05162 | 0.30233411 |
| 96 | Galactose metabolism_Homo sapiens_hsa00052 | 0.27520347 |
| 97 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.26134631 |
| 98 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.25995584 |
| 99 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.25873265 |
| 100 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.25430127 |
| 101 | Other glycan degradation_Homo sapiens_hsa00511 | 0.25064366 |
| 102 | Alcoholism_Homo sapiens_hsa05034 | 0.24999288 |
| 103 | Retinol metabolism_Homo sapiens_hsa00830 | 0.24928173 |
| 104 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.24750298 |
| 105 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.24562250 |
| 106 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.24153279 |
| 107 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.23775466 |
| 108 | Pertussis_Homo sapiens_hsa05133 | 0.23628095 |
| 109 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.22483241 |
| 110 | Thyroid cancer_Homo sapiens_hsa05216 | 0.22396144 |
| 111 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.21147955 |
| 112 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.20868366 |
| 113 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.20151837 |
| 114 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.19789033 |
| 115 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.19751476 |
| 116 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.19515260 |
| 117 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.18918341 |
| 118 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.18385301 |
| 119 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.17813383 |
| 120 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.17082537 |
| 121 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.16639623 |
| 122 | Apoptosis_Homo sapiens_hsa04210 | 0.14418733 |
| 123 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.14296504 |
| 124 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.14181861 |
| 125 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.11711209 |
| 126 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.11421497 |
| 127 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.11163345 |
| 128 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.11010876 |
| 129 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.10827155 |
| 130 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.10686313 |
| 131 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.10648824 |

